Rheumatism experience differs depending on gender, study suggests
15 Sep 2008

Rheumatoid arthritis is often more painful for women than for men, despite the fact that visible symptoms are the same and doctors should take more account of these differences when assessing medication requirements, it has been suggested.

The findings of the research are being presented at a congress on gender medicine arranged by the Karolinska Institutet in Sweden.

Men who underwent standard therapy for rheumatism responded significantly better than their female counterparts who had the same treatment, the researchers found, both subjectively - in terms of their own experience of the condition - and objectively - such as the degree of swelling in their joints.

"Purely objectively, the drug had a somewhat better effect on the men than on the women ... But the greatest difference was of a subjective nature. The women in the study felt sicker even when their joints showed the same improvements," commented associate professor Ronald van Vollenhoven.

As such, he suggested that clinicians should take the subjective aspects of rheumatoid arthritis into account, given that their objective is to reduce suffering.

Login and visit the Arthritis Knowledge Centre

Print Article    Bookmark

• Vitamin E supplements do not reduce arthritis risk, study suggests 26/11/08
• Genetic link for psoriatic arthritis "unclear" 22/10/08
• Rheumatoid arthritis linked to joint surgery in the past, study states 03/10/08
• Occupational therapy and exercise increase physical activity in osteoarthritis sufferers, study suggests 30/09/08
• Parasitic worm secretion could help in arthritis treatment, researchers say 17/09/08

• HUMIRA 40 mg - 51.61%
  Rheumatoid arthritis Humira in combination with methotrexate, is indicated for: § the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. § the treatment of severe ...
  
  
• ECONAC - 51.61%
  ... in a wide range of conditions, including: arthritic conditions such as rheumatoid arthritis, osteo-arthritis, ankylosing spondylitis, acute gout; acute musculoskeletal disorders such as peri-arthritis (eg, frozen shoulder), tendinitis, tenosynovitis, bursitis; other painful conditions resulting from ...
  
  
• INDOCID - 49.42%
  Indocid Capsules and Indocid Suppositories: Rheumatoid arthritis, osteoarthritis, degenerative joint disease of the hip, ankylosing spondylitis, acute gouty arthritis, lumbago, acute peri-articular disorders, orthopaedic procedures. Dysmenorrhoea. Indocid-R: As above except acute gouty arthritis ...
  
  
• MOBIC - 48.68%
  ... symptomatic treatment of rheumatoid arthritis (chronic polyarthritis); symptomatic treatment of ankylosing spondylitis. Mobic Tablets: Osteoarthritis, 7.5 mg once daily at mealtimes. Increase if necessary to maximum 15 mg once daily. Rheumatoid arthritis, ankylosing spondylitis, 15 mg once daily ...
  
  
• ARCOXIA Film-coated Tablets - 47.95%
  For the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA) and the pain and signs of inflammation associated with acute gouty arthritis. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks (See ...
  
  
• PLAQUENIL - 47.95%
  Rheumatoid arthritis, juvenile rheumatoid arthritis, lupus erythematosus. Skin conditions erythematosus. Skin conditions aggravated by sunlight ...